Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

ChemoMetec

749.50 DKK

-0.86 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
-0.86 %
-5.07 %
+42.22 %
+42.49 %
+54.15 %
+53.71 %
-17.18 %
+71.51 %
+3,306.82 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
13.04B DKK
Turnover
9.23M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4.2.
2026

Interim report Q2'26

10.9.
2026

Annual report '26

8.10.
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release11/7/2025, 12:27 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/7/2025, 12:18 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/6/2025, 4:11 PM

Growth in revenue and operating profit

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release10/28/2025, 10:06 AM

Upgrade of guidance

ChemoMetec
Regulatory press release10/9/2025, 8:01 PM

Procedure of the Annual General Meeting

ChemoMetec
Regulatory press release9/17/2025, 1:43 PM

Notice of Annual General Meeting 2025

ChemoMetec
Regulatory press release9/11/2025, 5:16 PM

Annual Report 2024/25 - Growing revenue and EBITDA

ChemoMetec
Regulatory press release9/11/2025, 5:12 PM

Guidance for the 2025/26 financial year

ChemoMetec
Regulatory press release7/1/2025, 10:45 AM

Preliminary revenue figures for the 2024/25 financial year

ChemoMetec
Regulatory press release5/7/2025, 3:32 PM

Continued growth in revenue and operating profit

ChemoMetec
Regulatory press release2/10/2025, 3:43 PM

Notification of managers' transactions

ChemoMetec
Regulatory press release2/5/2025, 5:55 PM

Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings

ChemoMetec
Regulatory press release1/10/2025, 8:47 AM

Upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release12/9/2024, 12:35 PM

Major shareholder announcement – AIM International Mutual Funds

ChemoMetec
Regulatory press release12/9/2024, 12:34 PM

Major shareholder announcement – Invesco Ltd.

ChemoMetec
Regulatory press release12/3/2024, 2:56 PM

Upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release11/8/2024, 12:28 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/8/2024, 12:26 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/7/2024, 4:12 PM

Growth in revenue and operating profit

ChemoMetec
Regulatory press release10/22/2024, 3:35 PM

Closing of acquisition of Ovizio Imaging Systems SA

ChemoMetec
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.